| Positive predictive value of prostate imaging reporting and data system version 2 for the detection of clinically significant prostate cancer: a systematic review and meta-analysis E Mazzone, A Stabile, F Pellegrino, G Basile, D Cignoli, GO Cirulli, ... European urology oncology 4 (5), 697-713, 2021 | 113 | 2021 |
| The key combined value of multiparametric magnetic resonance imaging, and magnetic resonance imaging–targeted and concomitant systematic biopsies for the prediction of adverse … G Gandaglia, G Ploussard, M Valerio, A Mattei, C Fiori, M Roumiguié, ... European urology 77 (6), 733-741, 2020 | 97 | 2020 |
| Can negative prostate-specific membrane antigen positron emission tomography/computed tomography avoid the need for pelvic lymph node dissection in newly diagnosed prostate … A Stabile, A Pellegrino, E Mazzone, D Cannoletta, M de Angelis, ... European Urology Oncology 5 (1), 1-17, 2022 | 65 | 2022 |
| The impact of implementation of the European Association of Urology Guidelines Panel recommendations on reporting and grading complications on perioperative outcomes after … G Gandaglia, CA Bravi, P Dell’Oglio, E Mazzone, N Fossati, S Scuderi, ... European Urology 74 (1), 4-7, 2018 | 61 | 2018 |
| Surgical safety of radical cystectomy and pelvic lymph node dissection following neoadjuvant pembrolizumab in patients with bladder cancer: prospective assessment of … A Briganti, G Gandaglia, S Scuderi, A Gallina, R Colombo, N Fossati, ... European urology 77 (5), 576-580, 2020 | 60 | 2020 |
| Defining clinically meaningful positive surgical margins in patients undergoing radical prostatectomy for localised prostate cancer A Martini, G Gandaglia, N Fossati, S Scuderi, CA Bravi, E Mazzone, ... European Urology Oncology 4 (1), 42-48, 2021 | 55 | 2021 |
| Prostate-specific membrane antigen radioguided surgery to detect nodal metastases in primary prostate cancer patients undergoing robot-assisted radical prostatectomy and … G Gandaglia, E Mazzone, A Stabile, A Pellegrino, V Cucchiara, F Barletta, ... European urology 82 (4), 411-418, 2022 | 48 | 2022 |
| Prognostic implications of multiparametric magnetic resonance imaging and concomitant systematic biopsy in predicting biochemical recurrence after radical prostatectomy in … G Gandaglia, G Ploussard, M Valerio, G Marra, M Moschini, A Martini, ... European urology oncology 3 (6), 739-747, 2020 | 34 | 2020 |
| A feasibility study of preoperative pembrolizumab before radical nephroureterectomy in patients with high-risk, upper tract urothelial carcinoma: PURE-02 A Necchi, A Martini, D Raggi, V Cucchiara, M Colecchia, R Lucianò, ... Urologic Oncology: Seminars and Original Investigations 40 (1), 10. e1-10. e6, 2022 | 23 | 2022 |
| Standardising the assessment of patient-reported outcome measures in localised prostate cancer. A systematic review MM Ratti, G Gandaglia, E Alleva, L Leardini, ES Sisca, A Derevianko, ... European urology oncology 5 (2), 153-163, 2022 | 22 | 2022 |
| Relative contribution of sampling and grading to the quality of prostate biopsy: results from a single high-volume institution CA Bravi, E Vertosick, A Tin, S Scuderi, G Fallara, G Rosiello, E Mazzone, ... European urology oncology 3 (4), 474-480, 2020 | 17 | 2020 |
| Multiparametric magnetic resonance imaging of the prostate underestimates tumour volume of small visible lesions G Sorce, A Stabile, R Lucianò, G Motterle, S Scuderi, F Barletta, ... BJU international 129 (2), 201-207, 2022 | 15 | 2022 |
| How to optimize follow-up in patients with a suspicious multiparametric MRI and a subsequent negative targeted prostate biopsy. Results from a large, single-institution series F Barletta, A Stabile, E Mazzone, G Brembilla, G Sorce, F Pellegrino, ... Urologic Oncology: Seminars and Original Investigations 40 (3), 103. e17-103 …, 2022 | 12 | 2022 |
| Age and gleason score upgrading between prostate biopsy and radical prostatectomy: Is this still true in the multiparametric resonance imaging era? E Mazzone, A Stabile, G Sorce, F Pellegrino, F Barletta, G Motterle, ... Urologic Oncology: Seminars and Original Investigations 39 (11), 784. e1-784. e9, 2021 | 9 | 2021 |
| Identification of the optimal candidates for nodal staging with extended pelvic lymph node dissection among prostate cancer patients who underwent preoperative prostate … G Gandaglia, F Barletta, D Robesti, S Scuderi, P Rajwa, JG Rivas, ... European Urology Oncology 6 (6), 543-552, 2023 | 7 | 2023 |
| Optimizing prostate-targeted biopsy schemes in men with multiple mpMRI visible lesions: should we target all suspicious areas? Results of a two institution series A Stabile, F Barletta, G Motterle, F Pellegrino, G Sorce, E Mazzone, ... Prostate Cancer and Prostatic Diseases 24 (4), 1137-1142, 2021 | 7 | 2021 |
| Mapping european association of urology guideline practice across europe: an audit of androgen deprivation therapy use before prostate cancer surgery in 6598 cases in 187 … S MacLennan, N Azevedo, E Duncan, J Dunsmore, L Fullwood, N Lumen, ... European Urology 83 (5), 393-401, 2023 | 6 | 2023 |
| Oncological and safety profiles in patients undergoing simultaneous transurethral resection (TUR) of bladder tumour and TUR of the prostate E Laukhtina, M Moschini, W Krajewski, JYC Teoh, G Ploussard, F Soria, ... BJU international 131 (5), 571-580, 2023 | 6 | 2023 |
| Diagnostic and prognostic factors in patients with prostate cancer: a systematic review K Beyer, L Moris, M Lardas, A Haire, F Barletta, S Scuderi, M Molnar, ... BMJ open 12 (4), e058267, 2022 | 6 | 2022 |
| Diagnostic and prognostic factors in patients with prostate cancer: a systematic review protocol K Beyer, L Moris, M Lardas, A Haire, F Barletta, S Scuderi, E Vradi, ... BMJ open 11 (2), e040531, 2021 | 6 | 2021 |
Giorgio GandagliaUniversità Vita-Salute San Raffaele, Milan, ItalyVerified email at hsr.it
